RU2263112C2 - ПРОИЗВОДНЫЕ ДИГИДРОБЕНЗО[b][1,4]ДИАЗЕПИН-2-ОНА В КАЧЕСТВЕ АНТАГОНИСТОВ MGLUR2 II - Google Patents

ПРОИЗВОДНЫЕ ДИГИДРОБЕНЗО[b][1,4]ДИАЗЕПИН-2-ОНА В КАЧЕСТВЕ АНТАГОНИСТОВ MGLUR2 II Download PDF

Info

Publication number
RU2263112C2
RU2263112C2 RU2003130637/04A RU2003130637A RU2263112C2 RU 2263112 C2 RU2263112 C2 RU 2263112C2 RU 2003130637/04 A RU2003130637/04 A RU 2003130637/04A RU 2003130637 A RU2003130637 A RU 2003130637A RU 2263112 C2 RU2263112 C2 RU 2263112C2
Authority
RU
Russia
Prior art keywords
phenyl
diazepin
dihydrobenzo
tert
mmol
Prior art date
Application number
RU2003130637/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2003130637A (ru
Inventor
Гео АДАМ (DE)
Гео Адам
Эрвин ГЁЧИ (CH)
Эрвин ГЁЧИ
Венсан МЮТЕЛЬ (FR)
Венсан МЮТЕЛЬ
Юрген Вихманн (DE)
Юрген ВИХМАНН
Томас Иоганнес ВОЛЬТЕРИНГ (DE)
Томас Иоганнес ВОЛЬТЕРИНГ
Original Assignee
Ф.Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф.Хоффманн-Ля Рош Аг filed Critical Ф.Хоффманн-Ля Рош Аг
Publication of RU2003130637A publication Critical patent/RU2003130637A/ru
Application granted granted Critical
Publication of RU2263112C2 publication Critical patent/RU2263112C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2003130637/04A 2001-04-12 2002-04-02 ПРОИЗВОДНЫЕ ДИГИДРОБЕНЗО[b][1,4]ДИАЗЕПИН-2-ОНА В КАЧЕСТВЕ АНТАГОНИСТОВ MGLUR2 II RU2263112C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01109125.3 2001-04-12
EP01109125 2001-04-12

Publications (2)

Publication Number Publication Date
RU2003130637A RU2003130637A (ru) 2005-04-10
RU2263112C2 true RU2263112C2 (ru) 2005-10-27

Family

ID=8177126

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003130637/04A RU2263112C2 (ru) 2001-04-12 2002-04-02 ПРОИЗВОДНЫЕ ДИГИДРОБЕНЗО[b][1,4]ДИАЗЕПИН-2-ОНА В КАЧЕСТВЕ АНТАГОНИСТОВ MGLUR2 II

Country Status (37)

Country Link
US (1) US6544985B2 (enExample)
EP (1) EP1379511B1 (enExample)
JP (1) JP4071115B2 (enExample)
KR (1) KR100566171B1 (enExample)
CN (1) CN1264825C (enExample)
AR (1) AR035816A1 (enExample)
AT (1) ATE299868T1 (enExample)
AU (1) AU2002312788B2 (enExample)
BG (1) BG108254A (enExample)
BR (1) BR0208891A (enExample)
CA (1) CA2442557C (enExample)
CZ (1) CZ20033003A3 (enExample)
DE (1) DE60205100T2 (enExample)
DK (1) DK1379511T3 (enExample)
EC (1) ECSP034797A (enExample)
ES (1) ES2246012T3 (enExample)
GT (1) GT200200073A (enExample)
HR (1) HRP20030792A2 (enExample)
HU (1) HUP0400851A3 (enExample)
IL (2) IL157873A0 (enExample)
JO (1) JO2285B1 (enExample)
MA (1) MA27012A1 (enExample)
MX (1) MXPA03009311A (enExample)
MY (1) MY140271A (enExample)
NO (1) NO20034576L (enExample)
NZ (1) NZ528315A (enExample)
PA (1) PA8543301A1 (enExample)
PE (1) PE20021041A1 (enExample)
PL (1) PL367064A1 (enExample)
PT (1) PT1379511E (enExample)
RU (1) RU2263112C2 (enExample)
SI (1) SI1379511T1 (enExample)
SK (1) SK13682003A3 (enExample)
UY (1) UY27258A1 (enExample)
WO (1) WO2002083652A1 (enExample)
YU (1) YU79003A (enExample)
ZA (1) ZA200307243B (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200201026T2 (tr) 1999-10-15 2002-08-21 F.Hoffmann-La Roche Ag Benzodiazepin türevleri
CA2471642C (en) * 2001-12-27 2011-05-24 Taisho Pharmaceutical Co., Ltd. 6-fluorobicyclo[3.1.0]hexane derivatives
EP1925614A1 (en) * 2002-03-28 2008-05-28 Wisys Technology Foundation, Inc. Anxiolytic agents with reduced sedative and ataxic effects
ATE389640T1 (de) 2002-03-28 2008-04-15 Wisys Technology Found Inc Angstlösende wirkstoffe mit verminderten beruhigenden und ataktischen nebenwirkungen
WO2005014002A1 (en) * 2003-07-25 2005-02-17 F. Hoffmann-La Roche Ag Combination of mglur2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders
US7329662B2 (en) 2003-10-03 2008-02-12 Hoffmann-La Roche Inc. Pyrazolo-pyridine
US20060160823A1 (en) * 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
AU2005254657B2 (en) * 2004-06-21 2011-03-17 F. Hoffmann-La Roche Ag Pyrrazolo-pyrimidine derivatives
MX2007009106A (es) * 2005-02-11 2007-09-11 Hoffmann La Roche Derivados de pirazolo-pirimidina como antagonistas del receptor de glutamato metabotropico 2.
DK1863818T3 (da) 2005-03-23 2010-05-10 Hoffmann La Roche Acetylenyl-pyrazolo-pyrimidinderivater som mglur2-antagonister
TWI391380B (zh) * 2005-06-23 2013-04-01 Array Biopharma Inc 製備苯并咪唑化合物之方法
DE602006013493D1 (de) 2005-09-27 2010-05-20 Hoffmann La Roche Oxadiazolylpyrazolopyrimidine als mglur2-antagonisten
GB0600228D0 (en) * 2006-01-06 2006-02-15 Fermentas Uab Inactivation method
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200808751A (en) * 2006-04-13 2008-02-16 Astrazeneca Ab New compounds
KR101096476B1 (ko) 2006-09-20 2011-12-20 에프. 호프만-라 로슈 아게 4-옥소-2,3,4,5-테트라히드로-벤조[b][1,4]디아제핀 유도체
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
CN101657432B (zh) 2007-04-19 2013-04-10 弗·哈夫曼-拉罗切有限公司 二氢-苯并[b][1,4]二氮杂*-2-酮磺酰胺衍生物
DK2203439T3 (da) 2007-09-14 2011-04-18 Ortho Mcneil Janssen Pharm 1',3'-disubstituerede 4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4']-bipyridinyl-2'-oner
KR20100080597A (ko) * 2007-09-14 2010-07-09 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 1,3-이치환된-4-페닐-1h-피리딘-2-온
BRPI0817101A2 (pt) 2007-09-14 2017-05-09 Addex Pharmaceuticals Sa 4-(aril-x-fenil)-1h-piridin-2-onas 1,3-dissubstituídas
MX2010005110A (es) 2007-11-14 2010-09-09 Ortho Mcneil Janssen Pharm Derivados de imidazo[1,2-a]piridina y su uso como moduladores alostericos positivos de los receptores de glutamato metabotropico 2.
AU2009289784B2 (en) 2008-09-02 2012-03-22 Addex Pharma S.A. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
US8697689B2 (en) 2008-10-16 2014-04-15 Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
RU2512283C2 (ru) 2008-11-28 2014-04-10 Янссен Фармасьютикалз, Инк. Производные индола и бензоксазина в качестве модуляторов метаботропных глутаматных рецепторов
NZ596053A (en) 2009-05-12 2013-05-31 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JO2907B1 (en) 2009-05-12 2015-09-15 اديكس فرما اس ايه Pyridine derivatives 1, 2, 4 trisolo [4, 3-A] and their uses as positive LLs for 2MGLUR receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
BR112013000925A2 (pt) 2010-07-15 2020-12-01 Bayer Intellectual Property Gmbh compostos heterocíclicos como pesticidas
WO2012059432A1 (en) 2010-11-01 2012-05-10 Abbott Gmbh & Co. Kg N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
WO2012059431A1 (en) 2010-11-01 2012-05-10 Abbott Gmbh & Co. Kg Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
CN103298810B (zh) 2010-11-08 2016-03-16 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
EP2661435B1 (en) 2010-11-08 2015-08-19 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
CA2834548C (en) * 2011-04-28 2021-06-01 The Broad Institute, Inc. Inhibitors of histone deacetylase
JP5790195B2 (ja) * 2011-06-22 2015-10-07 セントラル硝子株式会社 ピラゾール化合物の製造方法
US9193710B2 (en) 2011-08-29 2015-11-24 Sanford-Burnham Medical Research Institute Benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof
WO2014018979A1 (en) 2012-07-27 2014-01-30 The Broad Institute, Inc. Inhibitors of histone deacetylase
AR093077A1 (es) 2012-10-23 2015-05-20 Hoffmann La Roche ANTAGONISTAS DE mGlu2/3 PARA EL TRATAMIENTO DE LOS TRASTORNOS AUTISTAS
WO2014100438A1 (en) 2012-12-20 2014-06-26 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
CA2896711C (en) 2012-12-28 2019-12-31 Crystalgenomics, Inc. 2,3-dihydro-isoindol-1-one derivatives and methods of use thereof as btk inhibitor
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
EA033889B1 (ru) 2014-01-21 2019-12-05 Янссен Фармацевтика Нв Комбинация на основе лиганда sv2a и положительного аллостерического модулятора метаботропного глутаматергического рецептора 2 подтипа
HUE045610T2 (hu) 2014-01-21 2020-01-28 Janssen Pharmaceutica Nv 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait vagy ortosztérikus agonistáit tartalmazó kombinációk és alkalmazásuk
EP4663636A2 (en) 2014-03-07 2025-12-17 BioCryst Pharmaceuticals, Inc. Trifluoromethyl substituted pyrazoles as human plasma kallikrein inhibitors
BR112016021727A2 (pt) 2014-04-23 2017-08-15 Hoffmann La Roche Antagonistas de mglu2/3 para o tratamento de incapacidades intelectuais
US9969726B2 (en) 2014-06-10 2018-05-15 Sanford-Burnham Medical Research Institute Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof
CN108727345B (zh) * 2017-04-25 2023-06-27 广东东阳光药业有限公司 一种咪唑环中间体的制备方法
CA3125731A1 (en) 2018-01-12 2019-07-18 KDAc Therapeutics, Inc. Combination of a selective histone deacetylase 3 (hdac3) inhibitor and an immunotherapy agent for the treatment of cancer
CN108586447B (zh) * 2018-01-19 2021-01-29 中国人民解放军第四军医大学 一种苯二氮杂卓化合物及其制备方法和应用
BR112021022538A2 (pt) * 2019-06-06 2021-12-28 Arcus Biosciences Inc Processos para preparar compostos de aminopirimidina

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU96102418A (ru) * 1995-02-09 1998-05-20 Егиш Дьордьсердьяр РТ Производные 1-[2-(замещенный винил)]-3,4-дигидро-5н-2,3-бензодиазепина, способ их получения, применение их для получения фармацевтического состава, фармацевтический состав и способ лечения заболеваний центральной нервной системы
WO2001010846A2 (en) * 1999-08-05 2001-02-15 Igt Pharma Inc. 1,4-diazepine derivatives for the treatment of diseases related to the central nervous system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU224435B1 (hu) * 1995-02-09 2005-10-28 EGIS Gyógyszergyár Rt. Benzodiazepin-származékok, eljárás előállításukra, alkalmazásukra és ezeket tartalmazó gyógyászati készítmények
SK283859B6 (sk) * 1995-02-09 2004-03-02 Egis Gy�Gyszergy�R Rt. 1-[2'-(Substituovaný)vinyl]-5H-2,3-benzodiazepínové deriváty, spôsob ich prípravy a medziprodukty na ich prípravu, liečivá ich obsahujúce a ich použitie
HUP0203142A3 (en) * 1999-10-15 2003-03-28 Hoffmann La Roche Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
TR200201026T2 (tr) * 1999-10-15 2002-08-21 F.Hoffmann-La Roche Ag Benzodiazepin türevleri

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU96102418A (ru) * 1995-02-09 1998-05-20 Егиш Дьордьсердьяр РТ Производные 1-[2-(замещенный винил)]-3,4-дигидро-5н-2,3-бензодиазепина, способ их получения, применение их для получения фармацевтического состава, фармацевтический состав и способ лечения заболеваний центральной нервной системы
RU96102669A (ru) * 1995-02-09 1998-05-20 Эгиш Дьодьсердьяр РТ Производные 1-[2-(замещенный винил)]-5н-2,3-бензодиазепина, способ их получения, промежуточное соединение, фармацевтический состав и способ его получения, способ лечения заболеваний центральной нервной системы
WO2001010846A2 (en) * 1999-08-05 2001-02-15 Igt Pharma Inc. 1,4-diazepine derivatives for the treatment of diseases related to the central nervous system

Also Published As

Publication number Publication date
YU79003A (sh) 2006-05-25
SK13682003A3 (sk) 2004-07-07
CN1264825C (zh) 2006-07-19
CZ20033003A3 (cs) 2004-05-12
CA2442557A1 (en) 2002-10-24
KR20030087076A (ko) 2003-11-12
IL157873A0 (en) 2004-03-28
JP2004529925A (ja) 2004-09-30
JO2285B1 (en) 2005-09-12
ZA200307243B (en) 2004-12-16
CA2442557C (en) 2008-12-23
HK1068888A1 (en) 2005-05-06
MXPA03009311A (es) 2004-02-12
GT200200073A (es) 2002-11-07
NZ528315A (en) 2005-04-29
HUP0400851A3 (en) 2010-03-29
RU2003130637A (ru) 2005-04-10
DE60205100D1 (de) 2005-08-25
BR0208891A (pt) 2004-04-20
MA27012A1 (fr) 2004-12-20
CN1535266A (zh) 2004-10-06
WO2002083652A1 (en) 2002-10-24
EP1379511B1 (en) 2005-07-20
MY140271A (en) 2009-12-31
ATE299868T1 (de) 2005-08-15
DE60205100T2 (de) 2006-06-01
PE20021041A1 (es) 2002-11-19
US20020193367A1 (en) 2002-12-19
NO20034576D0 (no) 2003-10-10
UY27258A1 (es) 2002-10-31
HRP20030792A2 (en) 2005-10-31
PT1379511E (pt) 2005-10-31
ES2246012T3 (es) 2006-02-01
SI1379511T1 (en) 2005-10-31
IL157873A (en) 2008-11-26
PA8543301A1 (es) 2003-01-24
AR035816A1 (es) 2004-07-14
KR100566171B1 (ko) 2006-03-29
US6544985B2 (en) 2003-04-08
JP4071115B2 (ja) 2008-04-02
PL367064A1 (en) 2005-02-21
ECSP034797A (es) 2003-12-01
NO20034576L (no) 2003-11-12
HUP0400851A2 (hu) 2004-07-28
AU2002312788B2 (en) 2005-11-10
DK1379511T3 (da) 2005-11-07
EP1379511A1 (en) 2004-01-14
BG108254A (bg) 2004-09-30

Similar Documents

Publication Publication Date Title
RU2263112C2 (ru) ПРОИЗВОДНЫЕ ДИГИДРОБЕНЗО[b][1,4]ДИАЗЕПИН-2-ОНА В КАЧЕСТВЕ АНТАГОНИСТОВ MGLUR2 II
AU2002312788A1 (en) Dihydro-benzo [b] [1, 4] diazepin-2-one derivatives as mGluR2 antagonists II
US6548495B2 (en) Dihydro-benzo [B] [1,4] diazepin-2-one derivatives
US20080113967A1 (en) Enzyme modulators and treatments
KR20020047237A (ko) 벤조디아제핀 유도체
AU2002310912A1 (en) Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mGluR2 antagonists I
TW200306824A (en) Tachykinin receptor antagonists
RU45093U1 (ru) Пылеуловитель
TWI296622B (en) Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mglur2 antagonists ii

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20090403